It was mainly expressed in epithelial cells but not in fibroblast cells, indicating that WFDC2 might be a novel biomarker and be involved in the development of EMT in CRSwNP. This evidence concerns the gene WFDC2 and chronic rhinosinusitis with nasal polyps.